Neogen | NEOG - Operating Profit


Neogen reported $-1.8M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Cerus USD -1.45M 488K Dec/2024
Danaher USD 1.25B 118M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
Illumina USD 305M 45M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Neogen USD -1.8M 4.9M Jun/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quidel USD 12.1M 27.4M Sep/2026
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD 5.46M 4.64M Sep/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Utah Medical Products USD 2.56M 124K Mar/2026
Zoetis USD 1.03B 88M Sep/2026